Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationStem CellsTransplantation ConditioningGraft vs Host DiseaseTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationHematopoiesisBone Marrow TransplantationHematopoietic Stem Cell MobilizationTransplantation ChimeraAntigens, CD34Tissue DonorsCell DifferentiationCord Blood Stem Cell TransplantationBone Marrow CellsCell LineageGraft SurvivalTreatment OutcomeStem Cell NicheWhole-Body IrradiationEmbryonic Stem CellsAdult Stem CellsHistocompatibility TestingBusulfanMyeloablative AgonistsHistocompatibilityChimerismLeukemiaMesenchymal Stem Cell TransplantationColony-Forming Units AssayGraft vs Leukemia EffectMice, Inbred C57BLRetrospective StudiesFlow CytometryRecurrenceBone MarrowFetal BloodHematologic DiseasesLiver TransplantationPluripotent Stem CellsStem Cell FactorMultipotent Stem CellsTime FactorsLeukemia, Myeloid, AcuteImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseCells, CulturedMyelodysplastic SyndromesHLA AntigensRemission InductionCell TransplantationCombined Modality TherapyCell SeparationSiblingsMultiple MyelomaUnrelated DonorsCell ProliferationVidarabineMesenchymal Stromal CellsSevere Combined ImmunodeficiencyGranulocyte Colony-Stimulating FactorSurvival RateGraft vs Tumor EffectDisease-Free SurvivalTransplantation ImmunologyMice, SCIDSurvival AnalysisHematopoietic SystemNeural Stem CellsFetal Stem CellsMelphalanLymphocyte TransfusionTransplantation, IsogeneicInduced Pluripotent Stem CellsMesonephrosCyclophosphamideLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesAnemia, AplasticMice, Inbred NODCytomegalovirus InfectionsSalvage TherapyCell Culture TechniquesKidney TransplantationAllograftsLymphopoiesisDonor SelectionAntilymphocyte SerumAcute DiseaseLymphocyte DepletionAntigens, CDFollow-Up StudiesProto-Oncogene Proteins c-kitLentivirusAntineoplastic Combined Chemotherapy Protocols